Systemic Nutrient and Stress Signaling via Myokines and Myometabolites

Annual Review of Physiology

Volumn 78, Issue , 2016, Pages 85-107

  Rai, Mamta ^a   Demontis, Fabio ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Aging; Endocrine; Longevity; Metabolic homeostasis; Nutrient sensing; Sarcopenia; Skeletal muscle; Systemic stress response

Indexed keywords

CYTOKINE; DRUG METABOLITE; MUSCLE DERIVED CYTOKINE; UNCLASSIFIED DRUG;

AGING; CELL DIFFERENTIATION; CELL ORGANELLE; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; INTERPERSONAL COMMUNICATION; LONGEVITY; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE REGENERATION; NUCLEAR REPROGRAMMING; NUTRIENT; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STRESS; TARGET ORGAN; ANIMAL; ENDOCRINE SYSTEM; FOOD; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CYTOKINES; ENDOCRINE SYSTEM; FOOD; HUMANS; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84958660395     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021115-105305     Document Type: Review

References (187)

1. Veatch JR, McMurray MA, Nelson ZW, Gottschling DE. 2009. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell 137:1247-58
2. Taylor RC, Berendzen KM, Dillin A. 2014. Systemic stress signalling: understanding the cell nonautonomous control of proteostasis.Nat. Rev. Mol. Cell Biol. 15:211-17
3. Metter EJ, Talbot LA, Schrager M, Conwit R. 2002. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J. Gerontol. A 57:B359-65
4. Nair KS. 2005. Aging muscle. Am. J. Clin. Nutr. 81:953-63
5. Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, et al. 2008. Association between muscular strength and mortality in men: prospective cohort study. BMJ 337:a439
6. Demontis F, Piccirillo R, Goldberg AL, PerrimonN. 2013. The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12:943-49
7. Demontis F, Piccirillo R, Goldberg AL, PerrimonN. 2013. Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models. Dis. Model. Mech. 6:1339-52
8. Piccirillo R, Demontis F, Perrimon N, Goldberg AL. 2014. Mechanisms of muscle growth and atrophy in mammals and Drosophila. Dev. Dyn. 243:201-15
9. Kim JK,MichaelMD, Previs SF, Peroni OD, Mauvais-Jarvis F, et al. 2000. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Investig. 105:1791-97
10. Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-69
11. Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. 2010. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch. Neurol. 67:428-33
12. Kuo YM, Kokjohn TA, Watson MD, Woods AS, Cotter RJ, et al. 2000. Elevated A β42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of A βPP metabolism.Am. J. Pathol. 156:797-805
13. Demontis F, PerrimonN. 2009. Integration of Insulin receptor/Foxo signaling and dMyc activity during muscle growth regulates body size in Drosophila. Development 136:983-93
14. GhoshA,Rideout EJ, Grewal SS. 2014. TIF-IA-dependent regulation of ribosome synthesis in Drosophila muscle is required to maintain systemic insulin signaling and larval growth. PLOS Genet. 10:e1004750
15. Knapp JR, Davie JK, Myer A, Meadows E, Olson EN, Klein WH. 2006. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 133:601-10
16. Anderson CM, Hu J, Barnes RM, Heidt AB, Cornelissen I, Black BL. 2015. Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice. Skelet. Muscle 5:7
17. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, et al. 2004. Regulation of muscle fiber type and running endurance by PPARδ. PLOS Biol. 2:e294
18. Luquet S,Lopez-Soriano J,Holst D, Fredenrich A, Melki J, et al. 2003. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 17:2299-301
19. Izumiya Y,Hopkins T,Morris C, SatoK, Zeng L, et al. 2008. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 7:159-72
20. McPherron AC, Lee SJ. 2002. Suppression of body fat accumulation inmyostatin-deficient mice. J. Clin. Investig. 109:595-601
21. McPherron AC, Lawler AM, Lee SJ. 1997. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387:83-90
22. Ryder JW, Bassel-Duby R, Olson EN, Zierath JR. 2003. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J. Biol. Chem. 278:44298-304
23. Zhou X, Wang JL, Lu J, Song Y, Kwak KS, et al. 2010. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531-43
24. Pedersen BK, Febbraio MA. 2012. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8:457-65
25. Webb AE, Brunet A. 2014. FOXO transcription factors: key regulators of cellular quality control. Trends Biochem. Sci. 39:159-69
26. Demontis F, PerrimonN. 2010. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 143:813-25
27. Bai H, Kang P, Hernandez AM, Tatar M. 2013. Activin signaling targeted by insulin/dFOXO regulates aging and muscle proteostasis in Drosophila. PLOS Genet. 9:e1003941
28. Tsai S, Sitzmann JM, Dastidar SG, Rodriguez AA, Vu SL, et al. 2015. Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity. J. Clin. Investig. 125:2952-64
29. Morley JF, Morimoto RI. 2004. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 15:657-64
30. van Oosten-Hawle P, Porter RS, Morimoto RI. 2013. Regulation of organismal proteostasis by transcellular chaperone signaling. Cell 153:1366-78
31. Sugi T, Nishida Y, Mori I. 2011. Regulation of behavioral plasticity by systemic temperature signaling in Caenorhabditis elegans. Nat. Neurosci. 14:984-92
32. Scott BA, Avidan MS, Crowder CM. 2002. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science 296:2388-91
33. Tohyama D, Yamaguchi A. 2010. A critical role of SNF1A/dAMPKα (Drosophila AMP-activated protein kinase α) in muscle on longevity and stress resistance in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 394:112-18
34. Vrailas-Mortimer A, del Rivero T,Mukherjee S, Nag S, Gaitanidis A, et al. 2011. A muscle-specific p38 MAPK/Mef2/MnSOD pathway regulates stress, motor function, and life span in Drosophila. Dev. Cell 21:783-95
35. Patel PH, Tamanoi F. 2006. Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress. J. Cell Sci. 119:4285-92
36. Chamoli M, Singh A, Malik Y, Mukhopadhyay A. 2014. A novel kinase regulates dietary restriction-mediated longevity in Caenorhabditis elegans. Aging Cell 13:641-55
37. Katewa SD, Demontis F, Kolipinski M, Hubbard A, Gill MS, et al. 2012. Intramyocellular fatty-acid metabolism plays a critical role in mediating responses to dietary restriction in Drosophila melanogaster. Cell Metab. 16:97-103
38. Hakimi P, Yang J, Casadesus G, MassillonD,Tolentino-SilvaF, et al. 2007. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J. Biol. Chem. 282:32844-55
39. Hanson RW, Hakimi P. 2008. Born to run; the story of the PEPCK-Cmus mouse. Biochimie 90:838-42
40. Stenesen D, Suh JM, Seo J, Yu K, Lee KS, et al. 2013. Adenosine nucleotide biosynthesis and AMPK regulate adult life span and mediate the longevity benefit of caloric restriction in flies. CellMetab. 17:101-12
41. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, et al. 2007. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 282:30014-21
42. Sczelecki S, Besse-Patin A, Abboud A, Kleiner S, Laznik-Bogoslavski D, et al. 2014. Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. Am. J. Physiol. Endocrinol. Metab. 306:E157-67
43. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. 2009. Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging. PNAS 106:20405-10
44. Jager S,Handschin C, St.-Pierre J, Spiegelman BM. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. PNAS 104:12017-22
45. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, et al. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγcoactivator-1. Mol. Cell 8:971-82
46. Li B, Nolte LA, Ju JS,Han DH, Coleman T, et al. 2000. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat. Med. 6:1115-20
47. Keipert S, Ost M, Chadt A, Voigt A, Ayala V, et al. 2013. Skeletal muscle uncoupling-induced longevity in mice is linked to increased substrate metabolism and induction of the endogenous antioxidant defense system. Am. J. Physiol. Endocrinol. Metab. 304:E495-506
48. Gates AC, Bernal-Mizrachi C, Chinault SL, Feng C, Schneider JG, et al. 2007. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metab. 6:497-505
49. Keipert S, Voigt A, Klaus S. 2011. Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice. Aging Cell 10:122-36
50. Duteil D, Chambon C, Ali F,Malivindi R, Zoll J, et al. 2010. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 12:496-508
51. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, et al. 2007. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131:476-91
52. Owusu-Ansah E, Song W, Perrimon N. 2013. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell 155:699-712
53. Demontis F, Patel VK, Swindell WR, Perrimon N. 2014. Intertissue control of the nucleolus via a myokine-dependent longevity pathway. Cell Rep. 7:1481-94
54. Patel VK, Demontis F. 2014. GDF11/myostatin and aging. Aging 6:351-52
55. Doroudgar S, Glembotski CC. 2011. The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol. Med. 17:207-14
56. Lee HY, Gattu AK, Camporez JP, Kanda S, Guigni B, et al. 2014. Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice. Diabetologia 57:1232-41
57. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, et al. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463-68
58. Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP,Horttanainen M, et al. 2013. Are skeletalmuscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J. Physiol. 591:5393-400
59. Timmons JA, Baar K, Davidsen PK, Atherton PJ. 2012. Is irisin a human exercise gene? Nature 488:E9-10, discussion E1
60. Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, et al. 2013. Evidence against a beneficial effect of irisin in humans. PLOS ONE 8:e73680
61. Servick K. 2015. Biomedicine. Woes for 'exercise hormone'. Science 347:1299
62. Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, et al. 2015. Irisin-A myth rather than an exercise-inducible myokine. Sci. Rep. 5:8889
63. Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, et al. 2014. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19:302-9
64. Barra NG, Chew MV, Holloway AC, Ashkar AA. 2012. Interleukin-15 treatment improves glucose homeostasis and insulin sensitivity in obese mice. Diabetes Obes. Metab. 14:190-93
65. Quinn LS, Anderson BG, Conner JD, Wolden-Hanson T. 2013. IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1 βexpression in male mice. Endocrinology 154:232-45
66. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argiles JM. 2009. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. Endocrinol. Metab. 296:E191-202
67. Ruas JL, White JP, Rao RR, Kleiner S, BrannanKT, et al. 2012.APGC-1αisoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151:1319-31
68. Rao RR, Long JZ, White JP, Svensson KJ, Lou J, et al. 2014. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157:1279-91
69. Yeh SH, Lai HL, Hsiao CY, Lin LW, Chuang YK, et al. 2014. Moderate physical activity of music aerobic exercise increases lymphocyte counts, specific subsets, and differentiation. J. Phys. Act. Health 11:1386-92
70. Pedersen L, Olsen CH, Pedersen BK, Hojman P. 2012. Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle. Am. J. Physiol. Endocrinol. Metab. 302:E831-40
71. Staiger H, Haas C, Machann J, Werner R, Weisser M, et al. 2009. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-δ and is of metabolic relevance in humans. Diabetes 58:579-89
72. Feldman BJ, Streeper RS, Farese RV Jr, Yamamoto KR. 2006. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. PNAS 103:15675-80
73. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, et al. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med. 17:1481-89
74. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK. 1998. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J. Physiol. 508(3):949-53
75. Kristiansen OP, Mandrup-Poulsen T. 2005. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54(Suppl. 2):114-24
76. Besse-Patin A, Montastier E, Vinel C, Castan-Laurell I, Louche K, et al. 2014. Effect of endurance training on skeletalmuscle myokine expression in obese men: identification of apelin as a novel myokine. Int. J. Obes. 38:707-13
77. Miyatake S, Manabe Y, Inagaki A, Furuichi Y, Takagi M, et al. 2014. Macrophage migration inhibitory factor diminishes muscle glucose transport induced by insulin and AICAR in a muscle type-dependent manner. Biochem. Biophys. Res. Commun. 444:496-501
78. GalaupA,Gomez E, Souktani R, DurandM,CazesA, et al. 2012. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125:140-49
79. Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, et al. 2009. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 29:969-74
80. Miyabe M, Ohashi K, Shibata R, Uemura Y, Ogura Y, et al. 2014. Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. Cardiovasc. Res. 103:111-20
81. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, et al. 2008. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 451:1008-12
82. Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, et al. 2013. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62:882-89
83. Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, Pedersen BK. 2011. Exercise-induced musclederived cytokines inhibit mammary cancer cell growth. Am. J. Physiol. Endocrinol. Metab. 301:E504-10
84. Aswad H, Forterre A, Wiklander OP, Vial G, Danty-Berger E, et al. 2014. Exosomes participate in the alteration ofmuscle homeostasis during lipid-induced insulin resistance in mice. Diabetologia 57:2155-64
85. Yoon JH, Kim D, Jang JH, Ghim J, Park S, et al. 2015. Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-FPR2 pathway in insulin resistance. Mol. Cell. Proteomics 14:882-92
86. White PJ, St.-Pierre P, Charbonneau A, Mitchell PL, St.-Amand E, et al. 2014. Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis. Nat. Med. 20:664-69
87. Chen T, Li Z, Zhang Y, Feng F,Wang X, et al. 2015. Muscle-selective knockout of AMPKα2 does not exacerbate diet-induced obesity probably related to altered myokines expression. Biochem. Biophys. Res. Commun. 458:449-55
88. Nishizawa H, Matsuda M, Yamada Y, Kawai K, Suzuki E, et al. 2004. Musclin, a novel skeletal muscle-derived secretory factor. J. Biol. Chem. 279:19391-95
89. Li YX, Cheng KC, Asakawa A, Kato I, Sato Y, et al. 2013. Role of musclin in the pathogenesis of hypertension in rat. PLOS ONE 8:e72004
90. Banzet S, Koulmann N, SanchezH, Serrurier B, PeinnequinA,BigardAX. 2007. Musclin gene expression is strongly related to fast-glycolytic phenotype. Biochem. Biophys. Res. Commun. 353:713-18
91. Yasui A, Nishizawa H, Okuno Y, Morita K, Kobayashi H, et al. 2007. Foxo1 represses expression of musclin, a skeletal muscle-derived secretory factor. Biochem. Biophys. Res. Commun. 364:358-65
92. Seldin MM, Peterson JM, Byerly MS,Wei Z, Wong GW. 2012. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J. Biol. Chem. 287:11968-80
93. Seldin MM, Lei X, Tan SY, Stanson KP,Wei Z, Wong GW. 2013. Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver. J. Biol. Chem. 288:36073-82
94. Kim KH, Jeong YT, Kim SH, Jung HS, Park KS, et al. 2013. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochem. Biophys. Res. Commun. 440:76-81
95. Keipert S, Ost M, Johann K, Imber F, Jastroch M, et al. 2014. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am. J. Physiol. Endocrinol. Metab. 306:E469-82
96. TyynismaaH, Carroll CJ, Raimundo N, Ahola-Erkkila S, Wenz T, et al. 2010. Mitochondrial myopathy induces a starvation-like response. Hum. Mol. Genet. 19:3948-58
97. Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A,Walsh K. 2008. FGF21 is an Akt-regulated myokine. FEBS Lett. 582:3805-10
98. Hojman P, Pedersen M, Nielsen AR, Krogh-Madsen R, Yfanti C, et al. 2009. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58:2797-801
99. Suomalainen A, Elo JM, Pietilainen KH, Hakonen AH, Sevastianova K, et al. 2011. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10:806-18
100. Hede MS, Salimova E, Piszczek A, Perlas E, Winn N, et al. 2012. E-peptides control bioavailability of IGF-1. PLOS ONE 7:e51152
101. Zeng L, Akasaki Y, Sato K, Ouchi N, Izumiya Y, Walsh K. 2010. Insulin-like 6 is induced by muscle injury and functions as a regenerative factor. J. Biol. Chem. 285:36060-69
102. Zeng L, Maruyama S, Nakamura K, Parker-Duffen JL, Adham IM, et al. 2014. The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis. Skelet. Muscle 4:16
103. Negishi S, Li Y, Usas A, Fu FH, Huard J. 2005. The effect of relaxin treatment on skeletal muscle injuries. Am. J. Sports Med. 33:1816-24
104. Mu X, Urso ML,Murray K, Fu F, Li Y. 2010. Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice. Am. J. Pathol. 177:2399-410
105. Serrano AL, Baeza-Raja B, Perdiguero E, JardiM,Munoz-Canoves P. 2008. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 7:33-44
106. Broholm C, Laye MJ, Brandt C, Vadalasetty R, Pilegaard H, et al. 2011. LIF is a contraction-induced myokine stimulating human myocyte proliferation. J. Appl. Physiol. 111:251-59
107. Hunt LC, Tudor EM, White JD. 2010. Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis. Exp. Cell Res. 316:1002-9
108. Guerci A, Lahoute C, Hebrard S, Collard L, Graindorge D, et al. 2012. Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. CellMetab. 15:25-37
109. Lafreniere JF, Mills P, Bouchentouf M, Tremblay JP. 2006. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp. Cell Res. 312:1127-41
110. Haugen F, Norheim F, Lian H, Wensaas AJ, Dueland S, et al. 2010. IL-7 is expressed and secreted by human skeletal muscle cells. Am. J. Physiol. Cell Physiol. 298:C807-16
111. Umemoto T, Furutani Y, Murakami M, Matsui T, Funaba M. 2011. Endogenous Bmp4 in myoblasts is required for myotube formation in C2C12 cells. Biochim. Biophys. Acta 1810:1127-35
112. Horsley V, Pavlath GK. 2003. Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 161:111-18
113. Kanzleiter T, Rath M, Gorgens SW, Jensen J, Tangen DS, et al. 2014. Themyokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem. Biophys. Res. Commun. 450:1089-94
114. Kishioka Y, Thomas M, Wakamatsu J, Hattori A, Sharma M, et al. 2008. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity. J. Cell. Physiol. 215:856-67
115. Straino S, Germani A, Di Carlo A, Porcelli D, De Mori R, et al. 2004. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110:3341-48
116. D'Amore PA, Brown RH Jr, Ku PT, Hoffman EP, Watanabe H, et al. 1994. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 35:362-65
117. Voss MW, Vivar C, Kramer AF, van Praag H. 2013. Bridging animal and human models of exerciseinduced brain plasticity. Trends Cogn. Sci. 17:525-44
118. Klein AB,WilliamsonR, Santini MA, Clemmensen C, Ettrup A, et al. 2011. BloodBDNFconcentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14:347-53
119. Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR. 2004. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 124:71-79
120. BanksWA, Kastin AJ, Gutierrez EG. 1994. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179:53-56
121. Piya MK, Harte AL, Sivakumar K, Tripathi G, Voyias PD, et al. 2014. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am. J. Physiol. Endocrinol. Metab. 306:E512-18
122. Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, et al. 2010. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 59:1817-24
123. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, et al. 2014. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344:630-34
124. Raichlen DA, Polk JD. 2013. Linking brains and brawn: exercise and the evolution of human neurobiology. Proc. R. Soc. B 280:20122250
125. Szlama G, Trexler M, Buday L, Patthy L. 2015. K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furin. FEBS Lett. 589:295-301
126. Garatachea N, Pinos T, Camara Y, Rodriguez-Romo G, Emanuele E, et al. 2013. Association of the K153R polymorphism in the myostatin gene and extreme longevity. Age 35:2445-54
127. Sinha M, Jang YC, Oh J, Khong D, Wu EY, et al. 2014. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344:649-52
128. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, et al. 2014. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344:630-34
129. Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, et al. 2014. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20:659-63
130. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, et al. 2013. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153:828-39
131. Zhang Y, Shao J, Wang Z, Yang T, Liu S, et al. 2015. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARγ. Gene 557:209-14
132. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, et al. 2015. GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab. 22:164-74
133. Houtkooper RH, Argmann C, Houten SM, Canto C, Jeninga EH, et al. 2011. The metabolic footprint of aging in mice. Sci. Rep. 1:134
134. Wolfe RR. 2006. The underappreciated role of muscle in health and disease.Am. J. Clin.Nutr. 84:475-82
135. Rennie MJ, Tipton KD. 2000. Protein and amino acid metabolism during and after exercise and the effects of nutrition. Annu. Rev. Nutr. 20:457-83
136. Nair KS, Short KR. 2005. Hormonal and signaling role of branched-chain amino acids. J. Nutr. 135:S1547-52
137. Jousse C, Averous J, Bruhat A, Carraro V, Mordier S, Fafournoux P. 2004. Amino acids as regulators of gene expression: molecular mechanisms. Biochem. Biophys. Res. Commun. 313:447-52
138. Brooks GA. 2009. Cell-cell and intracellular lactate shuttles. J. Physiol. 587:5591-600
139. Philp A, Macdonald AL, Watt PW. 2005. Lactate-A signal coordinating cell and systemic function. J. Exp. Biol. 208:4561-75
140. Corkey BE, ShirihaiO. 2012. Metabolic master regulators: sharing information amongmultiple systems. Trends Endocrinol. Metab. 23:594-601
141. Brosnan ME, Letto J. 1991. Interorgan metabolism of valine. Amino Acids 1:29-35
142. TraboldO,Wagner S,WickeC, ScheuenstuhlH,Hussain MZ, et al. 2003. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair. Regen. 11:504-9
143. Hashimoto T, Hussien R, Oommen S, Gohil K, Brooks GA. 2007. Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis. FASEB J. 21:2602-12
144. Bergersen LH. 2015. Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction. J. Cereb. Blood Flow Metab. 35:176-85
145. van Hall G, van der Vusse GJ, Soderlund K, Wagenmakers AJ. 1995. Deamination of amino acids as a source for ammonia production in human skeletal muscle during prolonged exercise. J. Physiol. 489(1):251-61
146. Graham TE,MacLean DA. 1992. Ammonia and amino acid metabolism in human skeletal muscle during exercise. Can. J. Physiol. Pharmacol. 70:132-41
147. Calvani R, Joseph AM, Adhihetty PJ, Miccheli A, Bossola M, et al. 2012. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol. Chem. 394:393-414
148. He C, Sumpter R Jr, Levine B. 2012. Exercise induces autophagy in peripheral tissues and in the brain. Autophagy 8:1548-51
149. Eng CH, Yu K, Lucas J, White E, Abraham RT. 2010. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal. 3:ra31
150. Hellsten Y. 1999. The effect of muscle contraction on the regulation of adenosine formation in rat skeletal muscle cells. J. Physiol. 518(3):761-68
151. Vergauwen L, Hespel P, Richter EA. 1994. Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J. Clin. Investig. 93:974-81
152. Zuberova M, Fenckova M, Simek P, Janeckova L, Dolezal T. 2010. Increased extracellular adenosine in Drosophila that are deficient in adenosine deaminase activates a release of energy stores leading to wasting and death. Dis. Models Mech. 3:773-84
153. HanDH, Hansen PA,Nolte LA, Holloszy JO. 1998. Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47:1671-75
154. Gnad T, Scheibler S, von Kugelgen I, Scheele C, Kilic A, et al. 2014. Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors. Nature 516:395-99
155. SandonaD,Danieli-Betto D, Germinario E, BiralD,Martinello T, et al. 2005. TheT-tubulemembrane ATP-operated P2X4 receptor influences contractility of skeletal muscle. FASEB J. 19:1184-86
156. Araya R, RiquelmeMA, Brandan E, Saez JC. 2004. The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP. Brain Res. Brain Res. Rev. 47:174-88
157. Kim MS, Lee J, Ha J, Kim SS, Kong Y, et al. 2002. ATP stimulates glucose transport through activation of P2 purinergic receptors in C2C12 skeletal muscle cells. Arch. Biochem. Biophys. 401:205-14
158. Burnstock G. 2006. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58:58-86
159. Michel T, FeronO. 1997. Nitric oxide synthases:which,where, how, and why? J. Clin. Investig. 100:2146-52
160. Nguyen HX, Tidball JG. 2003. Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation duringmodifiedmuscle use inmice. J. Physiol. 550:347-56
161. Hamann M, Chamoin MC, Portalier P, Bernheim L, Baroffio A, et al. 1995. Synthesis and release of an acetylcholine-like compound by human myoblasts and myotubes. J. Physiol. 489(3):791-803
162. Roberts LD, Bostrom P, O'Sullivan JF, Schinzel RT, Lewis GD, et al. 2014. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 19:96-108
163. Shimomura Y, Honda T, Shiraki M, Murakami T, Sato J, et al. 2006. Branched-chain amino acid catabolism in exercise and liver disease. J. Nutr. 136:S250-53
164. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The Orphan G protein-coupled receptorsGPR41 andGPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-19
165. Patti GJ, Tautenhahn R, Johannsen D, Kalisiak E, Ravussin E, et al. 2014. Meta-analysis of global metabolomic data identifies metabolites associated with life-span extension. Metabolomics 10:737-43
166. Agudelo LZ, FemeniaT,Orhan F, Porsmyr-PalmertzM,GoinyM, et al. 2014. Skeletal musclePGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159:33-45
167. WaldropTG, Stremel RW. 1989. Muscular contraction stimulates posterior hypothalamic neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 256:R348-56
168. Coll AP, Yeo GS. 2013. The hypothalamus and metabolism: integrating signals to control energy and glucose homeostasis. Curr. Opin. Pharmacol. 13:970-76
169. Sagot Y, Rosse T, Vejsada R, Perrelet D, Kato AC. 1998. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J. Neurosci. 18:1132-41
170. Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Price DL. 1993. Evidence that brainderived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10:359-67
171. Gomez-Pinilla F, Ying Z, Opazo P, Roy RR, Edgerton VR. 2001. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur. J. Neurosci. 13:1078-84
172. Bongiovanni A, Romancino DP, Campos Y, Paterniti G, Qiu X, et al. 2012. Alix protein is substrate of Ozz-E3 ligase and modulates actin remodeling in skeletal muscle. J. Biol. Chem. 287:12159-71
173. Ritzenthaler S, Suzuki E, Chiba A. 2000. Postsynaptic filopodia in muscle cells interact with innervating motoneuron axons. Nat. Neurosci. 3:1012-17
174. Demontis F, Dahmann C. 2007. Apical and lateral cell protrusions interconnect epithelial cells in live Drosophila wing imaginal discs. Dev. Dyn. 236:3408-18
175. Kornberg TB, Roy S. 2014. Cytonemes as specialized signaling filopodia. Development 141:729-36
176. Norheim F, Raastad T, Thiede B, Rustan AC, Drevon CA, Haugen F. 2011. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301:E1013-21
177. Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, et al. 2013. A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 341:399-402
178. Kwiatkowski DJ, Mehl R, Izumo S,Nadal-Ginard B, YinHL. 1988. Muscle is themajor source of plasma gelsolin. J. Biol. Chem. 263:8239-43
179. Swynghedauw B. 1986. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66:710-71
180. Manabe Y, Takagi M, Nakamura-Yamada M, Goto-Inoue N, Taoka M, et al. 2014. Redox proteins are constitutively secreted by skeletal muscle. J. Physiol. Sci. 64:401-9
181. Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ. 2010. Non-classical exocytosis of α-synuclein is sensitive to folding states and promoted under stress conditions. J. Neurochem. 113:1263-74
182. Choo HJ, Kim BW, Kwon OB, Lee CS, Choi JS, Ko YG. 2008. Secretion of adenylate kinase 1 is required for extracellular ATP synthesis in C2C12 myotubes. Exp. Mol. Med. 40:220-28
183. Vult von Steyern F, Josefsson JO. 1995. Secretion of plasminogen activator and lysosomal enzymes from mouse skeletal muscle: effect of denervation. J. Cell. Physiol. 164:555-61
184. Romancino DP, Paterniti G, Campos Y, De Luca A, Di Felice V, et al. 2013. Identification and characterization of the nano-sized vesicles released by muscle cells. FEBS Lett. 587:1379-84
185. GuesciniM, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, et al. 2010. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp. Cell Res. 316:1977-84
186. Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, et al. 2014. Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle 13:78-89
187. Panakova D, Sprong H, Marois E, Thiele C, Eaton S. 2005. Lipoprotein particles are required for Hedgehog andWingless signalling. Nature 435:58-65